BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 12360044)

  • 1. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis.
    Montgomery E; Torbenson MS; Kaushal M; Fisher C; Abraham SC
    Am J Surg Pathol; 2002 Oct; 26(10):1296-301. PubMed ID: 12360044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.
    Bhattacharya B; Dilworth HP; Iacobuzio-Donahue C; Ricci F; Weber K; Furlong MA; Fisher C; Montgomery E
    Am J Surg Pathol; 2005 May; 29(5):653-9. PubMed ID: 15832090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis.
    Yantiss RK; Spiro IJ; Compton CC; Rosenberg AE
    Am J Surg Pathol; 2000 Jul; 24(7):947-57. PubMed ID: 10895817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.
    Miettinen M; Monihan JM; Sarlomo-Rikala M; Kovatich AJ; Carr NJ; Emory TS; Sobin LH
    Am J Surg Pathol; 1999 Sep; 23(9):1109-18. PubMed ID: 10478672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor.
    Shidham VB; Chivukula M; Gupta D; Rao RN; Komorowski R
    Arch Pathol Lab Med; 2002 Oct; 126(10):1189-92. PubMed ID: 12296756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
    Miettinen M; Sobin LH; Sarlomo-Rikala M
    Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
    Abraham SC; Reynolds C; Lee JH; Montgomery EA; Baisden BL; Krasinskas AM; Wu TT
    Hum Pathol; 2002 Jan; 33(1):39-46. PubMed ID: 11823972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of gastrointestinal stromal tumor and other spindle cell tumors in the gastrointestinal tract based on immunohistochemical analysis.
    Yamaguchi U; Hasegawa T; Masuda T; Sekine S; Kawai A; Chuman H; Shimoda T
    Virchows Arch; 2004 Aug; 445(2):142-50. PubMed ID: 15232741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial fibromatoses are genetically distinct from deep fibromatoses.
    Montgomery E; Lee JH; Abraham SC; Wu TT
    Mod Pathol; 2001 Jul; 14(7):695-701. PubMed ID: 11455002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: a study of 100 cases.
    Thway K; Gibson S; Ramsay A; Sebire NJ
    Pediatr Dev Pathol; 2009; 12(4):292-6. PubMed ID: 18939887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
    Coco DP; Hirsch MS; Hornick JL
    Am J Surg Pathol; 2009 Dec; 33(12):1795-801. PubMed ID: 19950405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
    Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
    Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of β-Catenin and LEF1 Immunohistochemical Stains in Desmoid-type Fibromatosis and its Selected Mimickers, With Unexpected Finding of LEF1 Positivity in Scars.
    Zou Y; Zhang Y; Church J; Liu X
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):648-653. PubMed ID: 28027119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses.
    Monihan JM; Carr NJ; Sobin LH
    Histopathology; 1994 Nov; 25(5):469-73. PubMed ID: 7532614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-kit immunocytochemical staining in the cytologic diagnosis of metastatic gastrointestinal stromal tumor. A report of two cases.
    Cheuk W; Lee KC; Chan JK
    Acta Cytol; 2000; 44(4):679-85. PubMed ID: 10934966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
    Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
    Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract.
    Yamaguchi U; Hasegawa T; Sakurai S; Sakuma Y; Takazawa Y; Hishima T; Mitsuhashi T; Sekine S; Chuman H; Shimoda T
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):46-51. PubMed ID: 16540730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
    Hauben EI; Jundt G; Cleton-Jansen AM; Yavas A; Kroon HM; Van Marck E; Hogendoorn PC
    Hum Pathol; 2005 Sep; 36(9):1025-30. PubMed ID: 16153468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.
    Lacroix-Triki M; Geyer FC; Lambros MB; Savage K; Ellis IO; Lee AH; Reis-Filho JS
    Mod Pathol; 2010 Nov; 23(11):1438-48. PubMed ID: 20693983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M; Majidi M; Lasota J
    Eur J Cancer; 2002 Sep; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.